Concepts (231)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Angiotensin II | 5 | 2016 | 159 | 1.980 |
Why?
|
| Tumor Necrosis Factor-alpha | 15 | 2016 | 668 | 1.540 |
Why?
|
| Myocardium | 12 | 2014 | 907 | 1.230 |
Why?
|
| Fibrosis | 12 | 2016 | 428 | 1.160 |
Why?
|
| Fibroblasts | 11 | 2016 | 879 | 1.020 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type I | 3 | 2016 | 33 | 0.980 |
Why?
|
| Cardiomegaly | 3 | 2013 | 125 | 0.760 |
Why?
|
| Myocytes, Cardiac | 6 | 2014 | 653 | 0.660 |
Why?
|
| Cardiomyopathies | 4 | 2009 | 508 | 0.570 |
Why?
|
| Chemokine CCL2 | 4 | 2010 | 119 | 0.530 |
Why?
|
| rho-Associated Kinases | 3 | 2013 | 51 | 0.490 |
Why?
|
| Ventricular Remodeling | 4 | 2014 | 167 | 0.450 |
Why?
|
| Lipopolysaccharides | 6 | 2003 | 306 | 0.430 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2014 | 87 | 0.410 |
Why?
|
| Myocardial Reperfusion Injury | 3 | 2009 | 130 | 0.400 |
Why?
|
| I-kappa B Proteins | 3 | 2003 | 39 | 0.370 |
Why?
|
| Kidney Diseases | 1 | 2016 | 488 | 0.360 |
Why?
|
| Heart Diseases | 1 | 2016 | 512 | 0.350 |
Why?
|
| NF-kappa B | 7 | 2003 | 455 | 0.350 |
Why?
|
| Mice, Inbred C57BL | 12 | 2016 | 4773 | 0.340 |
Why?
|
| Mice, Knockout | 11 | 2016 | 3888 | 0.320 |
Why?
|
| Vasoconstrictor Agents | 1 | 2010 | 140 | 0.310 |
Why?
|
| Cell Differentiation | 4 | 2013 | 1990 | 0.310 |
Why?
|
| Cell Transdifferentiation | 1 | 2009 | 61 | 0.290 |
Why?
|
| Collagen | 5 | 2013 | 309 | 0.290 |
Why?
|
| Receptors, IgG | 1 | 2008 | 62 | 0.280 |
Why?
|
| Animals | 27 | 2016 | 35136 | 0.280 |
Why?
|
| Papio | 4 | 2003 | 60 | 0.270 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2009 | 356 | 0.270 |
Why?
|
| Myocardial Ischemia | 3 | 2007 | 341 | 0.270 |
Why?
|
| Inflammation Mediators | 3 | 2014 | 243 | 0.250 |
Why?
|
| Mice | 19 | 2016 | 18622 | 0.250 |
Why?
|
| Signal Transduction | 6 | 2013 | 4737 | 0.250 |
Why?
|
| Apoptosis | 4 | 2007 | 1907 | 0.230 |
Why?
|
| Bone Marrow Cells | 1 | 2006 | 263 | 0.230 |
Why?
|
| Formative Feedback | 1 | 2024 | 32 | 0.220 |
Why?
|
| Endotoxemia | 1 | 2003 | 55 | 0.200 |
Why?
|
| Cells, Cultured | 7 | 2013 | 3071 | 0.200 |
Why?
|
| Education, Medical, Undergraduate | 1 | 2024 | 159 | 0.190 |
Why?
|
| Membrane Glycoproteins | 2 | 2003 | 421 | 0.190 |
Why?
|
| Disease Models, Animal | 6 | 2009 | 4681 | 0.190 |
Why?
|
| Educational Measurement | 1 | 2024 | 329 | 0.180 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2016 | 1294 | 0.180 |
Why?
|
| Learning | 1 | 2024 | 370 | 0.170 |
Why?
|
| Acute-Phase Proteins | 1 | 2000 | 50 | 0.170 |
Why?
|
| Myocarditis | 2 | 2003 | 130 | 0.170 |
Why?
|
| Myocardial Infarction | 4 | 2012 | 1060 | 0.160 |
Why?
|
| Students, Medical | 1 | 2024 | 362 | 0.160 |
Why?
|
| Gene Expression | 3 | 2013 | 1569 | 0.140 |
Why?
|
| Flow Cytometry | 2 | 2016 | 806 | 0.120 |
Why?
|
| Sepsis | 1 | 2000 | 518 | 0.120 |
Why?
|
| Myofibroblasts | 2 | 2013 | 68 | 0.120 |
Why?
|
| DNA-Binding Proteins | 2 | 2001 | 2067 | 0.120 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2016 | 829 | 0.120 |
Why?
|
| Carrier Proteins | 1 | 2000 | 1053 | 0.120 |
Why?
|
| Cell Migration Assays | 1 | 2014 | 2 | 0.120 |
Why?
|
| Endotoxins | 4 | 2002 | 49 | 0.110 |
Why?
|
| RNA, Messenger | 4 | 2010 | 2714 | 0.110 |
Why?
|
| Inflammation | 6 | 2016 | 1526 | 0.110 |
Why?
|
| Promoter Regions, Genetic | 1 | 1998 | 1344 | 0.110 |
Why?
|
| Cytokines | 2 | 2013 | 1368 | 0.100 |
Why?
|
| Phosphatidylserines | 1 | 2013 | 49 | 0.100 |
Why?
|
| NF-KappaB Inhibitor alpha | 3 | 2003 | 33 | 0.100 |
Why?
|
| Transendothelial and Transepithelial Migration | 1 | 2013 | 9 | 0.100 |
Why?
|
| Mice, 129 Strain | 1 | 2013 | 100 | 0.100 |
Why?
|
| In Vitro Techniques | 2 | 2008 | 880 | 0.100 |
Why?
|
| Cell Size | 1 | 2013 | 86 | 0.100 |
Why?
|
| Myeloid Progenitor Cells | 1 | 2012 | 15 | 0.100 |
Why?
|
| Molecular Sequence Data | 4 | 2012 | 3838 | 0.090 |
Why?
|
| Coculture Techniques | 1 | 2013 | 239 | 0.090 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2013 | 134 | 0.090 |
Why?
|
| Kinetics | 3 | 2003 | 1214 | 0.090 |
Why?
|
| Interleukin-1 | 2 | 2003 | 137 | 0.090 |
Why?
|
| Heart | 1 | 2016 | 701 | 0.090 |
Why?
|
| Podocytes | 1 | 2012 | 77 | 0.090 |
Why?
|
| Hypertension | 2 | 2010 | 1342 | 0.090 |
Why?
|
| Blood Platelets | 1 | 2013 | 325 | 0.090 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2012 | 146 | 0.090 |
Why?
|
| Burns | 2 | 2002 | 101 | 0.080 |
Why?
|
| Cell Lineage | 1 | 2012 | 362 | 0.080 |
Why?
|
| Transfection | 2 | 2009 | 1020 | 0.080 |
Why?
|
| Enzyme Activation | 2 | 2012 | 616 | 0.080 |
Why?
|
| Mice, Transgenic | 4 | 2012 | 2460 | 0.080 |
Why?
|
| Interleukin-6 | 2 | 2003 | 438 | 0.080 |
Why?
|
| Mitochondrial Diseases | 1 | 2012 | 150 | 0.080 |
Why?
|
| Models, Animal | 1 | 2012 | 470 | 0.080 |
Why?
|
| Hyperglycemia | 1 | 2012 | 238 | 0.080 |
Why?
|
| Leukocyte Rolling | 1 | 2009 | 4 | 0.080 |
Why?
|
| Smad3 Protein | 1 | 2009 | 58 | 0.080 |
Why?
|
| Kidney | 1 | 2016 | 1332 | 0.080 |
Why?
|
| Caspases | 2 | 2007 | 165 | 0.080 |
Why?
|
| Male | 11 | 2024 | 64994 | 0.070 |
Why?
|
| Humans | 15 | 2024 | 132278 | 0.070 |
Why?
|
| Amino Acid Sequence | 3 | 2012 | 2696 | 0.070 |
Why?
|
| Serum Amyloid P-Component | 1 | 2008 | 14 | 0.070 |
Why?
|
| Endothelial Cells | 1 | 2012 | 531 | 0.070 |
Why?
|
| Lung Diseases, Interstitial | 1 | 2010 | 173 | 0.070 |
Why?
|
| STAT1 Transcription Factor | 1 | 2008 | 75 | 0.070 |
Why?
|
| Shock, Septic | 2 | 2001 | 156 | 0.070 |
Why?
|
| Hyaluronan Receptors | 1 | 2008 | 62 | 0.070 |
Why?
|
| Cell Movement | 2 | 2008 | 894 | 0.070 |
Why?
|
| Cytochromes c | 1 | 2007 | 53 | 0.070 |
Why?
|
| Hypertrophy | 1 | 2007 | 101 | 0.070 |
Why?
|
| RNA Interference | 1 | 2009 | 519 | 0.070 |
Why?
|
| Hemodynamics | 2 | 2009 | 855 | 0.070 |
Why?
|
| Receptors, Chemokine | 1 | 2007 | 47 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2007 | 181 | 0.060 |
Why?
|
| Chimera | 1 | 2006 | 84 | 0.060 |
Why?
|
| Leukocyte Common Antigens | 1 | 2006 | 91 | 0.060 |
Why?
|
| Antigens, CD34 | 1 | 2006 | 109 | 0.060 |
Why?
|
| Amyloid | 1 | 2006 | 67 | 0.060 |
Why?
|
| Monocytes | 1 | 2008 | 345 | 0.060 |
Why?
|
| Chemokines, CXC | 1 | 2006 | 38 | 0.060 |
Why?
|
| Thrombospondin 1 | 1 | 2005 | 23 | 0.060 |
Why?
|
| Heart Failure | 2 | 2012 | 2386 | 0.060 |
Why?
|
| DNA Primers | 2 | 2012 | 639 | 0.060 |
Why?
|
| Up-Regulation | 2 | 2005 | 883 | 0.050 |
Why?
|
| Blood Cell Count | 1 | 2003 | 69 | 0.050 |
Why?
|
| Feedback | 1 | 2024 | 161 | 0.050 |
Why?
|
| Female | 9 | 2024 | 70774 | 0.050 |
Why?
|
| Platelet Count | 1 | 2003 | 140 | 0.050 |
Why?
|
| Myocardial Contraction | 2 | 2003 | 254 | 0.050 |
Why?
|
| Stem Cells | 1 | 2008 | 737 | 0.050 |
Why?
|
| Body Temperature | 1 | 2003 | 128 | 0.050 |
Why?
|
| Cardiac Output | 1 | 2003 | 166 | 0.050 |
Why?
|
| Regeneration | 1 | 2005 | 227 | 0.050 |
Why?
|
| Endothelium, Vascular | 2 | 2005 | 490 | 0.050 |
Why?
|
| Interleukin-8 | 1 | 2003 | 212 | 0.050 |
Why?
|
| Protein Kinases | 1 | 2003 | 332 | 0.050 |
Why?
|
| Plasma | 1 | 2002 | 103 | 0.050 |
Why?
|
| NF-kappa B p50 Subunit | 1 | 2001 | 10 | 0.040 |
Why?
|
| Transcription Factor RelA | 1 | 2001 | 54 | 0.040 |
Why?
|
| Coronary Vessels | 2 | 2003 | 549 | 0.040 |
Why?
|
| Receptors, Cell Surface | 1 | 2003 | 458 | 0.040 |
Why?
|
| Vitamin E | 1 | 2001 | 65 | 0.040 |
Why?
|
| Vitamin A | 1 | 2001 | 59 | 0.040 |
Why?
|
| Ascorbic Acid | 1 | 2001 | 77 | 0.040 |
Why?
|
| Heart Rate | 1 | 2003 | 572 | 0.040 |
Why?
|
| CHO Cells | 1 | 2000 | 159 | 0.040 |
Why?
|
| Molecular Weight | 1 | 2000 | 327 | 0.040 |
Why?
|
| Cricetinae | 1 | 2000 | 386 | 0.040 |
Why?
|
| Time Factors | 3 | 2009 | 6454 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2003 | 1674 | 0.040 |
Why?
|
| Protein Transport | 1 | 2001 | 371 | 0.040 |
Why?
|
| Cell Proliferation | 1 | 2006 | 2515 | 0.040 |
Why?
|
| Cicatrix | 2 | 2012 | 123 | 0.040 |
Why?
|
| Curriculum | 1 | 2024 | 762 | 0.040 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 1998 | 64 | 0.040 |
Why?
|
| Antioxidants | 1 | 2001 | 335 | 0.040 |
Why?
|
| Luciferases | 1 | 1998 | 130 | 0.040 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 1998 | 272 | 0.040 |
Why?
|
| Blood Pressure | 1 | 2003 | 1372 | 0.030 |
Why?
|
| Species Specificity | 1 | 1998 | 549 | 0.030 |
Why?
|
| Genes, Reporter | 1 | 1998 | 368 | 0.030 |
Why?
|
| Gene Expression Regulation | 3 | 2005 | 2492 | 0.030 |
Why?
|
| DNA, Complementary | 1 | 1997 | 456 | 0.030 |
Why?
|
| Transcription, Genetic | 1 | 2001 | 1530 | 0.030 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 1997 | 658 | 0.030 |
Why?
|
| Sequence Deletion | 1 | 1998 | 532 | 0.030 |
Why?
|
| Oxidative Stress | 1 | 2001 | 802 | 0.030 |
Why?
|
| Chemokines | 2 | 2006 | 131 | 0.030 |
Why?
|
| Lim Kinases | 1 | 2013 | 7 | 0.030 |
Why?
|
| Cofilin 1 | 1 | 2013 | 12 | 0.030 |
Why?
|
| Base Sequence | 1 | 1998 | 2990 | 0.030 |
Why?
|
| Thrombin | 1 | 2013 | 59 | 0.030 |
Why?
|
| Platelet Aggregation | 1 | 2013 | 107 | 0.030 |
Why?
|
| Amides | 1 | 2013 | 87 | 0.030 |
Why?
|
| DNA | 1 | 1998 | 1530 | 0.020 |
Why?
|
| Glomerular Basement Membrane | 1 | 2012 | 9 | 0.020 |
Why?
|
| Pyridines | 1 | 2013 | 248 | 0.020 |
Why?
|
| Dynamins | 1 | 2012 | 45 | 0.020 |
Why?
|
| Actins | 1 | 2013 | 339 | 0.020 |
Why?
|
| Gene Knock-In Techniques | 1 | 2012 | 124 | 0.020 |
Why?
|
| Extracellular Matrix | 1 | 2012 | 238 | 0.020 |
Why?
|
| Mutagenesis | 1 | 2012 | 351 | 0.020 |
Why?
|
| Sequence Alignment | 1 | 2012 | 619 | 0.020 |
Why?
|
| Heart Defects, Congenital | 1 | 2002 | 1867 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2012 | 1008 | 0.020 |
Why?
|
| Constriction | 1 | 2009 | 47 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2012 | 694 | 0.020 |
Why?
|
| Gene Deletion | 1 | 2012 | 797 | 0.020 |
Why?
|
| Thrombosis | 1 | 2013 | 529 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2002 | 1225 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2012 | 1610 | 0.020 |
Why?
|
| Adaptation, Physiological | 1 | 2009 | 279 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2009 | 684 | 0.020 |
Why?
|
| Receptors, CCR2 | 1 | 2007 | 24 | 0.020 |
Why?
|
| Cell Communication | 1 | 2008 | 187 | 0.020 |
Why?
|
| Receptors, Oncostatin M | 1 | 2006 | 1 | 0.020 |
Why?
|
| Oncostatin M | 1 | 2006 | 5 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2009 | 1045 | 0.020 |
Why?
|
| Chemokine CXCL1 | 1 | 2006 | 16 | 0.020 |
Why?
|
| Autophagy-Related Proteins | 1 | 2006 | 35 | 0.020 |
Why?
|
| NIH 3T3 Cells | 1 | 2006 | 96 | 0.020 |
Why?
|
| Receptors, Cytokine | 1 | 2006 | 67 | 0.020 |
Why?
|
| Aorta | 1 | 2009 | 554 | 0.020 |
Why?
|
| Rats | 2 | 2002 | 3631 | 0.010 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2005 | 158 | 0.010 |
Why?
|
| Reperfusion Injury | 1 | 2005 | 111 | 0.010 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2006 | 295 | 0.010 |
Why?
|
| Dogs | 1 | 2005 | 654 | 0.010 |
Why?
|
| Cytoprotection | 1 | 2003 | 38 | 0.010 |
Why?
|
| Ligation | 1 | 2003 | 130 | 0.010 |
Why?
|
| Interleukin-1 Receptor-Associated Kinases | 1 | 2003 | 22 | 0.010 |
Why?
|
| Toll-Like Receptors | 1 | 2003 | 84 | 0.010 |
Why?
|
| MicroRNAs | 1 | 2009 | 918 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2009 | 1880 | 0.010 |
Why?
|
| DNA Fragmentation | 1 | 2002 | 60 | 0.010 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2002 | 77 | 0.010 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2002 | 125 | 0.010 |
Why?
|
| Caspase 3 | 1 | 2002 | 140 | 0.010 |
Why?
|
| Immunoassay | 1 | 2002 | 135 | 0.010 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2002 | 121 | 0.010 |
Why?
|
| Culture Media | 1 | 2002 | 183 | 0.010 |
Why?
|
| Cytosol | 1 | 2001 | 144 | 0.010 |
Why?
|
| Body Surface Area | 1 | 2001 | 35 | 0.010 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2001 | 152 | 0.010 |
Why?
|
| Injury Severity Score | 1 | 2001 | 229 | 0.010 |
Why?
|
| Proteins | 1 | 2006 | 1066 | 0.010 |
Why?
|
| Acute Disease | 1 | 2003 | 1176 | 0.010 |
Why?
|
| Cardiopulmonary Bypass | 1 | 2002 | 372 | 0.010 |
Why?
|
| Cell Nucleus | 1 | 2001 | 621 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2003 | 1228 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2002 | 1377 | 0.010 |
Why?
|
| Survival Rate | 1 | 2003 | 2186 | 0.010 |
Why?
|
| Cell Line | 1 | 2002 | 2759 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2002 | 6534 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2002 | 8558 | 0.000 |
Why?
|
| Infant | 1 | 2002 | 13177 | 0.000 |
Why?
|
| Child, Preschool | 1 | 2002 | 14831 | 0.000 |
Why?
|
| Adult | 1 | 2002 | 31585 | 0.000 |
Why?
|